PIPPI is located in Lyngby, Denmark on Kemitorvet 207. PIPPI is rated 3 out of 5 in the category pharmaceuticals in Denmark. The Consortium PIPPI Scientists in the field of structural and computational biology, biophysics, protein formulation and stability have formed the consortium “Protein-excipient Interactions and Protein-Protein Interactions in formulation”, PIPPI. The overall goal is to develop a public database with cutting-edge knowledge about the properties of proteins in pharmaceutical formulations. PIPPI, funded under the European Horizon2020 programme, is an Innovative Training Network (ITN) concerning the challenges in formulation of protein-based drugs. PIPPI will combine systematic investigations of the physicochemical behavior of a number of proteins with an in-depth understanding of the molecular interactions behind the macroscopic behavior. The overall objective is to develop methodologies, tools and databases to guide the formulation of robust protein-based therapeutics in the future. The consortium consists of both academic and industrial partners located in Denmark, Sweden, Germany and United Kingdom. Each of the project partners contributes excellent competence in their particular areas.
Company size
11-50 employees
Headquarters
Lyngby, Kgs. Lyngby